Alex Goldberg

Bristol-Myers Squibb Company (NYSE:BMY) and The Kroger Co. (NYSE:KR) Added to Equity Profile Report's NYSE Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/21/2014 -- Equity Profile Report expands its NYSE Gainers Weekly Watch List adding Bristol-Myers Squibb Company (NYSE:BMY) and The Kroger Co. (NYSE:KR).

Bristol-Myers Squibb Company (NYSE:BMY) a company that discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide closed up in its previous session (+0.73%) on 12,437,806 shares traded after BRISTOL MYERS SQUIBB CO Reported its Financials. Bristol-Myers Squibb Company (NYSE:BMY) is currently up (+48.44%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Gainers Watch List.

Click Here to find out what other Investors are saying about Bristol-Myers Squibb Company (NYSE:BMY)

The Kroger Co. (NYSE:KR) a company that together with its subsidiaries, operates as a retailer in the United States closed up in its previous session (+1.32%) on 5,917,517 shares traded after Kroger was Named a Top Organization for Multicultural Business Opportunities. The Kroger Co. (NYSE:KR) is currently up (+42.34%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Gainers Watch List.

Click Here to find out what other Investors are saying about The Kroger Co. (NYSE:KR)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com